APA (7th ed.) Citation

Momčilović, M., Šitum, I., Erceg, A., Siroglavić, M., Lovrić, M., Lovrić, M., . . . Lovrić, D. Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: A single-center randomized open-label trial (ZAVICONT). Rationale and design. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Momčilović, Mirna, et al. Continuous Infusion Versus Intermittent Dosing of Ceftazidime/avibactam in Critically Ill Patients with Klebsiella Pneumoniae OXA-48 or Pseudomonas Aeruginosa Infections: A Single-center Randomized Open-label Trial (ZAVICONT). Rationale and Design. Frontiers Media S.A.

MLA (9th ed.) Citation

Momčilović, Mirna, et al. Continuous Infusion Versus Intermittent Dosing of Ceftazidime/avibactam in Critically Ill Patients with Klebsiella Pneumoniae OXA-48 or Pseudomonas Aeruginosa Infections: A Single-center Randomized Open-label Trial (ZAVICONT). Rationale and Design. Frontiers Media S.A.